Sung et al. [9] used TMA intervention to modify an ACD mouse model and discussed the pharmacological effects of Achyranthis radix extract, which was proved to be an effective agent for treatment of ACD disease, the anti-inflammatory mechanism was that Achyranthis could attenuate the II-1β and TNF-α level in the ACD mouse body. The gene discussed is TNF; the disease is granular corneal dystrophy type II.